Bausch Execs Escape Derivative Suit Over Fraud Scheme
A New Jersey federal judge on Monday adopted a recommendation to dismiss a shareholder derivative class action that alleged executives of Canadian pharmaceutical company Bausch Health Cos. Inc. tried to cover...To view the full article, register now.
Already a subscriber? Click here to view full article